Search
for
Sort by
Research 211–240 of 1000+
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Recent Advances in Genetically Engineered Mouse Models of Melanoma: Insights into Tumor Initiation and Oncogenic Signaling Pathways
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- Treating Alopecia Areata: Current Practices Versus New Directions
- Dupilumab for alopecia areata treatment: A double‐edged sword?
- Alopecia Areata
- A Consensus Single-cell Atlas Of Hidradenitis Suppurativa Tunnels Defines A Fibro-inflammatory Niche With Druggable Microenvironmental Endotypes
- A Consensus Single-cell Atlas Of Hidradenitis Suppurativa Tunnels Defines A Fibro-inflammatory Niche With Druggable Microenvironmental Endotypes
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- In pemphigus, cell detachment, but not autoantibody binding, induces cell-wide, long-lasting transcriptomic and proteomic changes
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Mechanisms of autophagy and their implications in dermatological disorders